Cargando…

Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study

OBJECTIVE: Implantable cardioverter defibrillators can treat life-threatening arrhythmias, but may negatively influence the last phase of life if not deactivated. Advance care planning conversations can prepare patients for future decision-making about implantable cardioverter defibrillator deactiva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stoevelaar, Rik, Brinkman-Stoppelenburg, Arianne, van Driel, Anne Geert, van Bruchem-Visser, Rozemarijn L, Theuns, Dominic AMJ, Bhagwandien, Rohit E, Van der Heide, Agnes, Rietjens, Judith AC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Heart Failure and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993024/ https://www.ncbi.nlm.nih.gov/pubmed/31537636 http://dx.doi.org/10.1136/heartjnl-2019-315721

Ejemplares similares

The incidence and impact of implantable cardioverter defibrillator shocks in the last phase of life: An integrated review
por: Stoevelaar, Rik, et al.
Publicado: (2018)

Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records
por: Stoevelaar, Rik, et al.
Publicado: (2019)

Advance care planning and end-of-life care in patients with an implantable cardioverter defibrillator: The perspective of relatives
por: Stoevelaar, Rik, et al.
Publicado: (2021)

Implantable cardioverter defibrillators at the end of life: future perspectives on clinical practice
por: Stoevelaar, R., et al.
Publicado: (2020)

Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35%
por: Wasfy, Jason H, et al.
Publicado: (2023)

Role of N-terminal pro-B type natriuretic peptide as a predictor of poor outcomes in patients with HFrEF receiving primary prevention implantable cardioverter-defibrillator therapy: a systematic review and dose–response meta-analysis
por: Prameswari, Hawani Sasmaya, et al.
Publicado: (2023)

Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers
por: Hiermeier, Ursula M, et al.
Publicado: (2020)

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016)

Patient and Professional Factors That Impact the Perceived Likelihood and Confidence of Healthcare Professionals to Discuss Implantable Cardioverter Defibrillator Deactivation in Advanced Heart Failure: Results From an International Factorial Survey
por: Hill, Loreena, et al.
Publicado: (2018)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Effects of exercise during chemotherapy for breast cancer on long-term cardiovascular toxicity
por: Naaktgeboren, Willeke R, et al.
Publicado: (2023)

Prevalence of cardiotropic viruses in adults with clinically suspected myocarditis in South Africa
por: Hassan, Karim, et al.
Publicado: (2022)

Influence of sex and phenotype on cardiac outcomes in patients with Fabry disease
por: El Sayed, Mohamed, et al.
Publicado: (2021)

Long-term left ventricular remodelling after revascularisation for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging
por: Hassell, Mariella ECJ, et al.
Publicado: (2017)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Risk factors for longitudinal changes in left ventricular diastolic function among women and men
por: Rueda-Ochoa, Oscar L, et al.
Publicado: (2019)

Use of loop diuretics in patients with chronic heart failure: an observational overview
por: Scholte, Niels TB, et al.
Publicado: (2023)

Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates
por: Janoušek, J, et al.
Publicado: (2009)

MRI and CT coronary angiography in survivors of COVID-19
por: Singh, Trisha, et al.
Publicado: (2022)

Prospective development and validation of a model to predict heart failure hospitalisation
por: Cubbon, R M, et al.
Publicado: (2014)

Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
por: Medenwald, D, et al.
Publicado: (2014)

Endothelial function and left ventricular diastolic functional reserve in type 2 diabetes mellitus
por: Leung, Melissa, et al.
Publicado: (2014)

Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
por: Lampropulos, Julianna F, et al.
Publicado: (2014)

Vitamin D levels and left ventricular diastolic function
por: Pandit, Anil, et al.
Publicado: (2014)

Novel cardiac pacemaker-based human model of periodic breathing to develop real-time, pre-emptive technology for carbon dioxide stabilisation
por: Baruah, Resham, et al.
Publicado: (2014)

Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: correlation with cardiac MR
por: Suwa, Kenichiro, et al.
Publicado: (2014)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia: a multicentre cross-sectional cohort study
por: Chow, V, et al.
Publicado: (2014)

The influence of aortoseptal angulation on provocable left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
por: Critoph, Christopher Howell, et al.
Publicado: (2014)

In-hospital treatment and outcomes of heart failure in specialist and non-specialist services: a retrospective cohort study in the elderly
por: Parmar, Kishan R, et al.
Publicado: (2015)

Predictors and prognostic value of left atrial remodelling after acute myocardial infarction
por: Kyhl, Kasper, et al.
Publicado: (2015)

Left ventricular diastolic reserve in patients with type 2 diabetes mellitus
por: Leung, Melissa, et al.
Publicado: (2015)

Clinical prediction of incident heart failure risk: a systematic review and meta-analysis
por: Yang, Hong, et al.
Publicado: (2015)

Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
por: Bank, Alan J, et al.
Publicado: (2015)

Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy
por: Tateishi, Emi, et al.
Publicado: (2015)

The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD
por: Buchan, Alice, et al.
Publicado: (2015)

Ischaemia change with revascularisation versus medical therapy in reduced ejection fraction
por: Mentz, Robert J, et al.
Publicado: (2015)

Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery
por: Prior, David L, et al.
Publicado: (2015)

Adding point of care ultrasound to assess volume status in heart failure patients in a nurse-led outpatient clinic. A randomised study
por: Gundersen, Guri Holmen, et al.
Publicado: (2016)

Prevalence and prognostic impact of kidney disease on heart failure patients
por: Löfman, Ida, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rp6p2khhnjhv7idmlmh1dh5vk5